Bernstein raises Vertex Pharmaceuticals (NASDAQ:VRTX) price target from $380 to $390

By / / Bernstein, Vertex

Bernstein analyst William Pickering maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price target from $380 to $390.

Scroll to Top